| Gender | Smoking status |  | |||
---|---|---|---|---|---|---|
 | Male (n = 94) | Female (n = 25) | None (n = 44) | Former (n = 23) | Current (n = 52) | Total (n = 119) |
Male, n (%) | - | - | 30 (68) | 21 (91) | 43 (83) | 94 (79) |
White, n (%) | 83 (88) | 13 (52) | 28 (64) | 19 (83) | 49 (94) | 96 (81)***## |
Age (years), mean (SD) | 44.5 (8.3) | 39.2 (7.7) | 42.7 (7.7) | 46.0 (8.8) | 42.8 (8.8) | 43.4 (8.4) ** |
Years of living with HIV, mean (SD) | 9.6 (6.7) | 6.9 (6.0) | 7.3 (5.8) | 10.6 (6.9) | 9.7 (7.0) | 9.0 (6.6) |
On HAART, n (%) | 86 (92) | 14 (56) | 35 (80) | 22 (96) | 43 (83) | 100 (84) *** |
CD4 (cells/mm3), mean (SD) | 478 (264) | 505 (312) | 510 (261) | 402 (252) | 498 (291) | 484 (274) |
Undetectable viral load, n (%) | 62 (66) | 11 (44) | 25 (57) | 17 (74) | 31 (60) | 73 (61) |
Pack-years in smokers1, mean (SD) | 24.0 (17.6) | 24.0 (20.7) | - | 16.8 (13.9) | 27.2 (18.7) | 24.0 (18.0)# |
Marijuana use | Â | Â | Â | Â | Â | ### |
   None, n (%) | 42 (45) | 18 (72) | 34 (77) | 9 (39) | 17 (33) | 60 (50) |
   Former, n (%) | 24 (26) | 5 (20) | 7 (16) | 8 (35) | 14 (27) | 29 (24) |
   Current, n (%) | 28 (30) | 2 (8) | 3 (7) | 6 (26) | 21 (40) | 30 (25) |
FEV1 before salbutamol (litres), mean (SD) | 3.8 (0.7) | 2.7 (0.5) | 3.48 (0.87) | 3.46 (0.81) | 3.62 (0.79) | 3.5 (0.8)*** |
%FEV1 before salbutamol (%), mean (SD) | 94.7 (15.8) | 86.9 (14.1) | 93.6 (14.0) | 91.1 (18.3) | 93.5 (16.1) | 93.1 (15.7)* |
FVC before salbutamol (litres), mean (SD) | 4.9 (0.8) | 3.3 (0.7) | 4.26 (1.09) | 4.58 (0.89) | 4.76 (0.95) | 4.5 (1.0)*** |
%FVC before salbutamol (%), mean (SD) | 96.2 (12.5) | 88.2 (16.7) | 91.4 (13.7) | 94.6 (11.7) | 97.1 (14.4) | 94.5 (13.8)** |
Abnormal lung function2, n (%) | 16 (17) | 8 (32) | 8 (18%) | 4 (17%) | 12 (23%) | 24 (20) |
Asthma history, n (%) | 6 (7) | 7 (29) | 3 (7) | 3 (13) | 7 (14) | 13 (11)** |
Asthmatic by spirometry3, n (%) | 3 (3) | 2 (8) | 2 (5) | 1 (4) | 2 (4) | 5 (4) |
Cough, n (%) | 49 (52) | 12 (48) | 16 (36) | 8 (35) | 37 (71) | 61 (51)## |
Sputum, n (%) | 41 (44) | 10 (40) | 11 (25) | 8 (35) | 32 (63) | 51 (43)## |
Breathlessness, n (%) | 6 (6) | 2 (8) | 0 | 1 (4) | 7 (14) | 8 (7)# |
Any respiratory symptom4, n (%) | 51 (54) | 12 (48) | 16 (36) | 9 (39) | 38 (73) | 63 (53)## |
COPD5, n (%) | 4 (4) | 0 | 0 | 2 (9%) | 2 (4%) | 4 (3) |
Restrictive lung diseases6, n (%) | 3 (3) | 7 (28) | 6 (14%) | 1 (4%) | 3 (6%) | 10 (8)** |
Abnormal lung function2 or symptomatic4, n (%) | 17 (68) | 54 (57) | 20 (45) | 11 (48) | 40 (77) | 71 (60)## |